Skip to content

Evaluation of the efficacy of an intraoperative laparoscopic transversus abdominis plane block under visual control using bupivacaine for elective laparoscopic bowel surgery

Evaluation of the efficacy of an intraoperative laparoscopic transversus abdominis plane block under visual control using bupivacaine for elective laparoscopic bowel surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00024839
Enrollment
80
Registered
2021-04-13
Start date
2021-04-12
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal neoplasms Inflammatory bowel diseases Diverticulitis

Interventions

Group 1: Application of an intra-operativeTAP-Block (transversus-abdominis-plane-Block) with Bupivacain in laparoscopic surgery

Sponsors

Universitätsmedizin Mannheim, Chirurgische Klinik
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: • >18 years • ASA classes I-III • all elective and laparoscopic operations with resection of the colon • with or without ileostoma

Exclusion criteria

Exclusion criteria: • GFR 35 • DASS-Score above the threshold value for depression, stress or fear • allergy against bupivacaine or the used local anaesthetic

Design outcomes

Primary

MeasureTime frame
Amount of morphin equivalents used in the first 72h after surgery

Secondary

MeasureTime frame
• average and max. NRS pain score in the first 72 hours after surgery (recorded every 12 hours) • NRS pain score at arrival and departure from the recovery room • duration of hospital stay • side effects caused by tap block • progression of the postoperative ileus and complications in the 30 days after the surgery, classified by Clavien-Dindo • ERAS-compliance variables (clinical recovery) • duration of surgery (first incision to last suture) • duration of the tap block • pin-prick test of the analgesia of the abdominal wall

Countries

Germany

Contacts

Public ContactVanessa Hartwig

Universitätsmedizin MannheimChirurgische Klinik

vanessa.hartwig@umm.de06213831501

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026